MARKETSOne Reason PlasmaTech Biopharma (PTBI) Stock Is RallyingBy Kurumi FukushimaJun 11, 2015 11:45 AM EDT
MARKETSPlasmaTech Biopharma (PTBI) Stock Up After Licensing Juvenile Batten Disease TreatmentBy Tony OwusuJun 8, 2015 10:43 AM EDT
INVESTINGPlasmaTech Jump but CEO Sees More Gains Coming Down PipelineBy Bret KenwellMay 18, 2015 5:35 PM EDT
VIDEORare Disease Drug Demand, Soros Interest Raising PlasmaTech ProfileBy Gregg GreenbergMay 18, 2015 4:26 PM EDT
MARKETSPlasmaTech Biopharmaceuticals (PTBI) Stock Rises on 'Buy' Rating Coverage InitiationBy Tony OwusuMay 18, 2015 11:51 AM EDT
